Obesity Market Research Reports & Industry Analysis
Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come.
The definitions or measurement characteristics for overweight and obesity have varied over time. The varied definitions affect prevalence statistics and make it difficult to compare data from different studies. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 kg/m2 is defined as overweight, and a BMI of over 30 kg/m2 as obese. These markers provide the common benchmarks for assessment, but the risks of disease in all populations can increase progressively from lower BMI levels.
According to the World Health Organization, adult mean BMI levels of 22-23 kg.m2 are found in Africa and Asia, while levels of 25-27 kg.m2 are prevalent across North America, Europe, and in some Latin American, North African and Pacific Island countries. BMI increases among middle-aged elderly people, who are at the greatest risk of health complications. In countries undergoing nutrition transition, overnutrition often coexists with undernutrition. People with a BMI below 18.5 kg/m2 tend to be underweight.
Obesity Industry Research & Market Reports
-
Global Market for Anti-obesity Drugs
... 2023 through 2028 with a compound annual growth rate (CAGR) projection. The report analyzes anti-obesity drugs by drug types, assesses distribution channels, and provides an overview regarding product pipeline of major players in market. Leading ... Read More
-
Anti-Obesity Drugs Markets in China
... maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, ... Read More
-
Anti-Obesity Drugs Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Anti-Obesity Drugs Industry Forecasts - China Focus
... manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China ... Read More
-
Obesity Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Increasing Incidence of Obesity and Rising Healthcare Spending Fueling Market Expansion The global Obesity Surgery Devices Market is on the brink of significant growth, with a projected valuation of approximately US$ 3 Billion by the ... Read More
-
Patient Engagement Solutions Market based on by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) & Regional Outlook– Global Forecast up to 2030
... 2030 In order to find and gather data for this technical, financial, and market-oriented analysis of the Patient Engagement Solutions market, this market research study made considerable use of secondary sources, directories, and databases. To ... Read More
-
Health and Wellness in Australia
... a range of claims such as natural, organic, good source of minerals/vitamins, no sugar/no added sugar (particularly in beverages), low fat and high protein/fibre. Euromonitor International's Health and Wellness in Australia report tracks the developments ... Read More
-
Body Composition Analyzers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 1,149.6 Million by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2022-2028. A body composition analyzer (BCA) is an equipment that is used to measure weight, body fat, water percentage, BMR, DCI, ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
Asia Pacific Clinical Trials Market Forecast to 2028 – Regional Analysis – by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Asia Pacific clinical trials market is expected to grow from US$ 8,670.68 million in 2022 to US$ 13,114.04 million by 2028. It is estimated to grow ... Read More
-
Enteral Feeding Devices Market, By Product Type ( Feeding Tubes( Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube, Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector, Jejunostomy Tubes), By Age Group (ediatric, Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Enteral Feeding Devices Market, By ... Read More
-
Bariatric Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2023-2028. Bariatric surgery devices refer to the clinical equipment used for conducting bariatric procedures. These procedures aid in weight ... Read More
-
Intragastric Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 111.1 Million by 2028, exhibiting a growth rate (CAGR) of 11.9% during 2023-2028. An intragastric balloon is a saline- or gas-filled inflatable silicone balloon that is temporarily placed inside the stomach for losing ... Read More
-
Obesity Surgery Device Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Obesity Surgery Device Market Outlook ... Read More
-
United States PCOS Treatment Market By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Competition Forecast & Opportunities, 2028
... Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Competition Forecast & Opportunities, 2028 The United States PCOS Treatment Market is expected to grow at an impressive rate ... Read More
-
Metabolic Disorders Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Disease Type (Lysosomal Storage Diseases, Diabetes, Obesity, Inherited Metabolic Disorders, Hypercholesterolemia, Others), By Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy), By Region, By Competition Forecast & Opportunities, 2018-2028F
... Transplantation, Small Molecule Based Therapy, Substrate Reduction Therapy, Gene Therapy, Drug Therapy), By Region, By Competition Forecast & Opportunities, 2018-2028F Global Metabolic Disorders Therapeutics Market has valued at USD 63.70 billion in 2022 and is ... Read More
-
Metabolism Assays Market by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
... to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 7.8% during the forecast period. The growth of this market is majorly driven by the promotion of metabolic ... Read More
-
Cardiometabolic Diseases Global Market Report 2023 Including: 1) By Type: Chronic/Congestive Heart Failure; Hypertension; Type 2 Diabetes; Obesity 2) By Treatment: ACE inhibitors; Diuretics; Glucophage; Liposuction 3) By Dosage: Tablet; Injection 4) By Route Of Administration: Oral; Intravenous 5) By End-Users: Clinic; Hospital Covering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc.
... By End-Users: Clinic; HospitalCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc. Cardiometabolic Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Obesity Intervention Devices Market - Global Obesity Intervention Devices Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product Coverage, By End User Coverage, By Geographic Coverage and Leading Companies)
... Obesity Intervention Devices Market Poised to Reach Nearly $0.5 Billion by 2030 The global obesity intervention devices market is on an upward trajectory, with a forecasted valuation of close to $0.5 billion by the year ... Read More
-
Global Anti-Obesity Drugs Market - 2023-2030
... period 2023-2030. Obesity is a health disorder with surplus body fat gathered to an magnitude that it may generate a harmful consequence on health. It is typically comprehended as owning a body mass index (BMI) ... Read More
-
Digital Therapeutics Market Size, Share, and Analysis, By Type (Devices, Software & Services), By Application (Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, Others), By End User (Patients, Providers, Payers, Employers, Others) and Regional Forecasts, 2022-2032
... Forecasts, 2022-2032 Digital Therapeutics Market Size, Share, and Analysis, By Type (Devices, Software & Services), By Application (Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases, Others), By End User (Patients, Providers, Payers, Employers, Others) ... Read More
-
Obesity Surgery Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price is presented ... Read More
Research Assistance
